NeoGenomics (NEO) News Today $10.27 +0.18 (+1.78%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$9.71 -0.56 (-5.44%) As of 04/25/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period NeoGenomics, Inc. (NASDAQ:NEO) Stock Position Increased by Oberweis Asset Management Inc.Oberweis Asset Management Inc. boosted its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 7.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 768,700 shares of the medical research cApril 26 at 7:34 AM | marketbeat.comNEO Battery Materials Appoints Kenneth Hoffman, Distinguished Battery Industry Leader and Former McKinsey's Global Head of Battery Materials, as New DirectorApril 25 at 9:07 AM | globenewswire.comNeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by Bank of Montreal CanBank of Montreal Can trimmed its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 99.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,623 shares of the medical research company's stock after sellingApril 25 at 3:26 AM | marketbeat.comGreenhouse Funds LLLP Grows Stock Position in NeoGenomics, Inc. (NASDAQ:NEO)Greenhouse Funds LLLP boosted its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 5.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,701,897 shares of the medical research companApril 24 at 7:34 AM | marketbeat.comNeoGenomics (NEO) Projected to Post Quarterly Earnings on TuesdayNeoGenomics (NASDAQ:NEO) will be releasing its Q1 2025 earnings before the market opens on Tuesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-4-29-neogenomics-inc-stock/)April 24 at 6:24 AM | marketbeat.comBridgewater Associates LP Sells 35,957 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Bridgewater Associates LP lowered its position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 71.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,397 shares of the medical researcApril 23 at 4:06 AM | marketbeat.comNeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual MeetingApril 22, 2025 | businesswire.comMirova Acquires Shares of 64,935 NeoGenomics, Inc. (NASDAQ:NEO)Mirova bought a new position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 64,935 shares of the medical research company's stock, valued at approximately $1,07April 22, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Stock Price Up 7.8% - Here's WhyNeoGenomics (NASDAQ:NEO) Trading Up 7.8% - Here's WhyApril 16, 2025 | marketbeat.comPiper Sandler Keeps Their Buy Rating on NeoGenomics (NEO)April 14, 2025 | markets.businessinsider.comNeoGenomics price target lowered to $12 from $16 at BofAApril 14, 2025 | markets.businessinsider.comF M Investments LLC Acquires Shares of 126,495 NeoGenomics, Inc. (NASDAQ:NEO)F M Investments LLC bought a new position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 126,495 shares of the medical research company's sApril 14, 2025 | marketbeat.comNorges Bank Makes New Investment in NeoGenomics, Inc. (NASDAQ:NEO)Norges Bank purchased a new position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 380,664 shares of the medical research company's stock, valued atApril 12, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Reaches New 1-Year Low - Here's WhyNeoGenomics (NASDAQ:NEO) Reaches New 12-Month Low - Should You Sell?April 11, 2025 | marketbeat.comNeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer TherapyApril 8, 2025 | globenewswire.comNeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025April 8, 2025 | businesswire.comNeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by Franklin Resources Inc.Franklin Resources Inc. lowered its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 28.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,461,406 shares of the medical research cApril 8, 2025 | marketbeat.comNeoGenomics Completes Acquisition of PathlineApril 7, 2025 | businesswire.comVanguard Group Inc. Grows Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO)Vanguard Group Inc. increased its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 1.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,239,887 shares of the medicalApril 7, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Receives Average Recommendation of "Moderate Buy" from AnalystsNeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) has been given an average rating of "Moderate Buy" by the ten brokerages that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommeApril 6, 2025 | marketbeat.com50,906 Shares in NeoGenomics, Inc. (NASDAQ:NEO) Bought by Raymond James Financial Inc.Raymond James Financial Inc. bought a new stake in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 50,906 shares of the medical research company's stock, valued at aApril 6, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Sets New 52-Week Low - Here's WhyNeoGenomics (NASDAQ:NEO) Sets New 12-Month Low - Should You Sell?April 5, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Short Interest UpdateNeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 4,220,000 shares, an increase of 20.9% from the February 28th total of 3,490,000 shares. Based on an average daily trading volume, of 1,220,000 shares, the short-interest ratio is currently 3.5 days. Currently, 3.3% of the shares of the stock are sold short.April 4, 2025 | marketbeat.comTesting & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)April 4, 2025 | finance.yahoo.comNeoGenomics CEO Chris Smith to depart, Tony Zook to succeedApril 2, 2025 | markets.businessinsider.comNeoGenomics announces CEO transitionApril 1, 2025 | msn.comNeoGenomics' New CEO Zook Takes Over as Smith RetiresApril 1, 2025 | marketwatch.comTony Zook Assumes Role as Chief Executive Officer of NeoGenomicsApril 1, 2025 | businesswire.comNeoGenomics (NEO) Gets a Hold from Benchmark Co.March 31, 2025 | markets.businessinsider.comLoomis Sayles & Co. L P Grows Position in NeoGenomics, Inc. (NASDAQ:NEO)Loomis Sayles & Co. L P lifted its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 48.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,791,792 shares of the medical resMarch 29, 2025 | marketbeat.comAmerican Century Companies Inc. Sells 132,683 Shares of NeoGenomics, Inc. (NASDAQ:NEO)American Century Companies Inc. decreased its position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 4.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,893,261 shares of the medical research company's stock after selling 132,68March 27, 2025 | marketbeat.comSegall Bryant & Hamill LLC Has $34.84 Million Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO)Segall Bryant & Hamill LLC grew its position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 11.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,113,822 shares of the medical research company's stock after buying an additiMarch 26, 2025 | marketbeat.comEmerald Advisers LLC Sells 124,777 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Emerald Advisers LLC decreased its position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 7.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,557,437 shares of the medical research company's stocMarch 24, 2025 | marketbeat.com3 Reasons to Sell NEO and 1 Stock to Buy InsteadMarch 21, 2025 | msn.comEarnings call transcript: NeoGenomics Q4 2024 results disappoint despite EPS beatMarch 21, 2025 | uk.investing.comCharles Schwab Investment Management Inc. Grows Stock Position in NeoGenomics, Inc. (NASDAQ:NEO)Charles Schwab Investment Management Inc. lifted its stake in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 2.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,161,352 shares of the medical research compaMarch 20, 2025 | marketbeat.comNeoGenomics COO Melody Harris to depart, Warren Stone to succeedMarch 19, 2025 | markets.businessinsider.comNeoGenomics names Warren Stone as chief operating officerMarch 18, 2025 | msn.comBTIG Keeps Their Buy Rating on NeoGenomics (NEO)March 18, 2025 | markets.businessinsider.comNeoGenomics Appoints Warren Stone as President & Chief Operating OfficerMarch 18, 2025 | finance.yahoo.comNEO Battery Showcases Mass-Producible Silicon Battery Prototype with Highest Capacity Retention Achieved to DateMarch 18, 2025 | globenewswire.comRoyce & Associates LP Boosts Holdings in NeoGenomics, Inc. (NASDAQ:NEO)Royce & Associates LP grew its position in shares of NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 5.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 675,866 shares of the medical research companMarch 18, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Shares Down 7% - Here's WhyNeoGenomics (NASDAQ:NEO) Trading Down 7% - Should You Sell?March 13, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Trading 7.2% Higher - Here's WhyNeoGenomics (NASDAQ:NEO) Trading Up 7.2% - Should You Buy?March 12, 2025 | marketbeat.comTD Cowen Sticks to Its Buy Rating for NeoGenomics (NEO)March 11, 2025 | markets.businessinsider.comNeoGenomics acquires Pathline, terms undisclosedMarch 10, 2025 | markets.businessinsider.comNeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of PathlineMarch 10, 2025 | finance.yahoo.comNeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Rating of "Moderate Buy" by BrokeragesNeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) has been given an average rating of "Moderate Buy" by the ten ratings firms that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The aMarch 10, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Releases FY 2025 Earnings GuidanceNeoGenomics (NASDAQ:NEO) updated its FY 2025 earnings guidance. The company provided EPS guidance of 0.150-0.190 for the period, compared to the consensus estimate of 0.200. The company also issued revenue guidance of $735.0 millionillion-$745.0 millionillion, compared to the consensus estimate of $735.0 millionillion.March 7, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Sets New 1-Year Low - Here's What HappenedNeoGenomics (NASDAQ:NEO) Hits New 12-Month Low - Here's WhyMarch 4, 2025 | marketbeat.com Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address NEO Media Mentions By Week NEO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEO News Sentiment▼1.181.03▲Average Medical News Sentiment NEO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEO Articles This Week▼85▲NEO Articles Average Week Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Etsy News Globant News Lyft News Amentum News MARA News WillScot Mobile Mini News Remitly Global News StoneCo News TriNet Group News Autohome News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEO) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NEO Stock Free NEO Stock Alerts